COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04510207
Recruitment Status : Recruiting
First Posted : August 12, 2020
Last Update Posted : October 30, 2020
G42 Healthcare company
Abu Dhabi Health Services Company
Wuhan Institute of Biological Products Co., Ltd
Beijing Institute of Biological Products Co., Ltd
Information provided by (Responsible Party):
China National Biotec Group Company Limited

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 16, 2021
Estimated Study Completion Date : September 16, 2021